These studies, including the original report of OPTN mutations in NTG, also suggest that the p.M98K OPTN variant could be an important disease risk factor, being present in 10–15% of glaucoma subjects compared with only 2–4% of normal controls. Here, OPA1 is linked to glaucoma.